Abstract | BACKGROUND AND AIMS:
Leptin is an adipokine that has several effects on metabolism and immune system in patients with ankylosing spondylitis (AS). The present investigations of the relationship between plasma/serum leptin levels and AS are contradictory. To derive a more precise estimation on the plasma/serum leptin levels in AS patients and related factors, a meta-analysis was performed. METHODS: Published literature that compares plasma/serum leptin levels between AS group and control group from PubMed, Embase, Cochrane Library and other databases were searched. The study quality was assessed by the Newcastle-Ottawa scale. Pooled standardized mean difference (SMD) with its 95% confidence interval (CI) was calculated by fixed-effects or random-effect model analyses. Statistical heterogeneity within studies was examined by the Q statistic. RESULTS: A total of eight studies including 391 AS patients and 293 healthy controls were finally included in the meta-analysis. No significant differences in plasma/serum leptin levels was found between AS patients and healthy controls when all studies were pooled into the meta-analysis (pooled SMD = 0.384, 95% CI = -1.522 to 0.753). Meanwhile, subgroup analyses by gender also showed no significant differences in plasma/serum leptin levels between case group and controls. CONCLUSION: There is no significant difference in plasma/serum leptin levels between AS patients and controls.
|
Authors | Yong-Jun Mei, Peng Wang, Lin-Jie Chen, Zhi-Jun Li |
Journal | Archives of medical research
(Arch Med Res)
Vol. 47
Issue 2
Pg. 111-7
(02 2016)
ISSN: 1873-5487 [Electronic] United States |
PMID | 27016486
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Copyright | Copyright © 2016 IMSS. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Adipokines
- Case-Control Studies
- Humans
- Leptin
(blood)
- Plasma
- Serum
- Spondylitis, Ankylosing
(blood)
|